During the last 10 years, there has been a growing interest in developing research related to neuromuscular diseases. There are therapies that have been tested in clinical trials and some of them are already available for patients in the United States and the European Union.
However, very little is known about the impact of neuromuscular diseases on the education and employment opportunities of both patients and their caregivers, and this can have a significant impact on their quality of life and their access to potential treatments in the future.
The diseases included in this study are the following:
- Muscular dystrophies (MD)
- Myotonic dystrophy (MD1 and MD2)
- Fascioscapulohumeral MD (FSHD)
- Limb girdle MD (LGMD)
- Congenital muscular distrophies
- Amyotrophic Lateral Sclerosis (ALS)
- Peripheral neuropathies
- Charcot Marie Tooth (CMT)
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Congenital myasthenias
- Congenital myopathies
Information provided directly by patients and their caregivers will allow us to understand the impact of rare neuromuscular diseases on the employment opportunities and the education of these patients and their families.